Division 28 - Psychopharmacology and Substance Abuse

Click here to go directly to the website of Division 28 - Psychopharmacology and Substance Abuse.

Division 28 - Psychopharmacology and Substance Abuse promotes teaching, research, and dissemination of information regarding the effects of drugs on behavior. Research often combines the methods of psychology and pharmacology to study the interaction of behavior, drugs, and other environmental factors in animals and humans. Psychopharmacology and substance abuse research is conducted in laboratory, clinical, and community settings. Division activities include addressing issues related to animal research, neurobehavioral toxicology, psychopharmacology training programs, development of new treatments for drug addiction, and public policy related to medication regulation and substance abuse.

A Closer Look: Click here to read about the division in the Monitor on Psychology, a publication of APA

Membership Application: http://www.apa.org/divisions/div28/div28brochure2008.pdf

President: Kimberly C. Kirby, PhD, Treatment Research Institute at University of PA, Philadelphia, PA

Secretary:Mark Smith, PhD, Davidson College

Newsletter: Psychopharmacology and Substance Abuse (published three times/year)
Editor: William W. Stoops, PhD, University of Kentucky College of Medicine

Division Meeting: APA Annual Convention, Boston, MA, August 14-17, 2008

Awards: www.apa.org/about/division/div28awards.html

List of Presidents: www.apa.org/about/division/div28pres.html

For Additional Information Contact: Nicole M. Avena, PhD, Membership Chair, Postdoctoral Fellow, The Rockefeller University, Laboratory of Behavioral Neurobiology, 1230 York Ave., Box 278, New York, NY 10021, office: 212-327-8438 or 609-258-3154, fax: 609-258-1113, email: Nicole M. Avena, PhD

Homepage: www.apa.org/divisions/div28